Samantha D’Anna
PhD
Senior Healthcare Management Consultant
Windsor, CT, US
Samantha D’Anna is a senior healthcare management consultant with the Hartford office of Milliman. She joined the firm in 2015.
Experience
Samantha provides consulting services to insurance companies, pharmacy benefit managers, Medicare plan sponsors, government entities, and nonprofit organizations.
Her primary work includes assisting Medicare Part D plan sponsors and other groups with strategic decisions around prescription drug plan pricing within the context of the current regulatory environment.
Publications and Presentations
- Co-author, Possible outcomes of potential disclosure requirements in Medicare Part D. Milliman White Paper, March 2023.
- Co-author, Self-reported health status of Medicare Part D beneficiaries. Millman Research Paper, November 2022.
- Co-author, Is Build Back Better Back? Overview of New Schumer Drug Pricing Reform. Milliman Briefing Note, July 2022.
- Co-author, A summary of insulin coverage in Medicare Part D. Milliman Report, June 2022.
- Co-author, Medicare Part D pharmacy price concessions at the point of sale. Milliman Report, February 2022.
- Co-author, A regulatory push to lower Part D costs at the pharmacy counter in 2023. Milliman Report, January 2022.
- Co-author, A demographic profile of Medicare Part D beneficiaries. Milliman White Paper, November 2021.
- Co-author, Reducing insulin costs for seniors: Thoughts for plan sponsors considering participation in the Medicare Part D Senior Savings Model. Milliman White Paper, March 2020.
- Co-author, A new Part D benefit design? Prescription Drug Pricing Reduction Act proposes major changes to Part D. Milliman White Paper, August 2019.
Education
- BA, Summa Cum Laude, Major: Psychology, Research Track, Minor: Neuroscience; University of Connecticut
- MA, Behavioral Neuroscience, University of Connecticut
- PhD, Behavioral Neuroscience, University of Connecticut
Publications